Structure Therapeutics Inc (GPCR) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Structure Therapeutics Inc   (NASDAQ: GPCR)


Structure Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Structure Therapeutics Inc 's ROA in the second quarter of 2026?
Structure Therapeutics Inc recorded a cumulative net loss of $-215 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -16.08%.

However, within the Healthcare sector 339 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3337, from total ROA ranking in the first quarter of 2026 at 3883.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 74.59 % 75.33 % 63.31 % -11.14 % -13.51 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -215 -170 -141 -211 -179
Return On Assets (TTM) -16.08 % -14.39 % -13.82 % -24.26 % -20.01 %
GPCR's Total Ranking # 3337 # 3883 # 3648 # 3591 # 3515
Total Assets (TTM) in million 1,425 1,508 1,584 827 816
Seq. Total Assets Change -5.48 % -4.79 % 91.6 % 1.26 % -5.08 %
Seq. Net Income Change - - - - -

GPCR's 5 Years Annual ROA >> Back to GPCR Management Effectiveness >> Compare GPCR ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 122
Sector # 340
Overall # 3343

Return On Assets Statistics
High Average Low
-13.78 %
-19.41 %
-30.5 %
(Dec 31 2025)   (Dec 31 2023)





Financial Statements
Structure Therapeutics Inc 's Assets $ 1,425 million GPCR's Balance sheet
Structure Therapeutics Inc 's Income $ -106 million Quarterly GPCR's Income Statement
GPCR's Income by Division See GPCR's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023
FY
FY
Y / Y Total Assets Change 75.86 % 88.49 % - - -
Total Assets in million 1,584 901 478 0 0
Y / Y Net Income Change - - - - -
Net Income in million -141 -123 -90 0 0
Annual Return On Assets -8.91 % -13.6 % -18.76 % - -

GPCR's 5 Years Annual ROA >> Back to GPCR Management Effectiveness >> Compare GPCR ROA to its Competitors



More Return On Assets Ratios
GPCR's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GPCR's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GPCR's Competitors
Subscribers only: Roa for Structure Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for GPCR's Customers

You may also want to know
GPCR's Roi GPCR's Inventory Turnover Ratio GPCR's Growth Rates GPCR's Dividend Comparisons
GPCR's Profitability Ratios GPCR's Asset Turnover Ratio GPCR's Dividend Growth
GPCR's Roe GPCR's Valuation Ratios GPCR's Financial Strength Ratios GPCR's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-08T01:17:30+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.